Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Am J Trop Med Hyg ; 105(3): 643-650, 2021 08 16.
Artículo en Inglés | MEDLINE | ID: mdl-34398818

RESUMEN

This cross-sectional study evaluated epidemiologic characteristics of persons living with HIV (PWH) coinfected with Trypanosoma cruzi in Cochabamba, Bolivia, and estimated T. cruzi parasitemia by real-time quantitative polymerase chain reaction (qPCR) in patients with and without evidence of reactivation by direct microscopy. Thirty-two of the 116 HIV patients evaluated had positive serology for T. cruzi indicative of chronic Chagas disease (27.6%). Sixteen of the 32 (50%) patients with positive serology were positive by quantitative polymerase chain reaction (qPCR), and four of the 32 (12.5%) were positive by direct microscopy. The median parasite load by qPCR in those with CD4+ < 200 was 168 parasites/mL (73-9951) compared with 28.5 parasites/mL (15-1,528) in those with CD4+ ≥ 200 (P = 0.89). There was a significant inverse relationship between the degree of parasitemia estimated by qPCR from blood clot and CD4+ count on the logarithmic scale (rsBC= -0.70, P = 0.007). The correlation between T. cruzi estimated by qPCR+ blood clot and HIV viral load was statistically significant with rsBC = 0.61, P = 0.047. Given the significant mortality of PWH and Chagas reactivation and that 57% of our patients with CD4+ counts < 200 cells/mm3 showed evidence of reactivation, we propose that screening for chronic Chagas disease be considered in PWH in regions endemic for Chagas disease and in the immigrant populations in nonendemic regions. Additionally, our study showed that PWH with advancing immunosuppression have higher levels of estimated parasitemia measured by qPCR and suggests a role for active surveillance for Chagas reactivation with consideration of treatment with antitrypanosomal therapy until immune reconstitution can be achieved.


Asunto(s)
Enfermedad de Chagas/sangre , Infecciones por VIH/sangre , Infección Latente/sangre , Parasitemia/sangre , Adulto , Anticuerpos Antiprotozoarios/inmunología , Bolivia , Recuento de Linfocito CD4 , Enfermedad de Chagas/complicaciones , Enfermedad de Chagas/diagnóstico , Enfermedad de Chagas/tratamiento farmacológico , Coinfección , Estudios Transversales , Femenino , Infecciones por VIH/complicaciones , Humanos , Infección Latente/complicaciones , Infección Latente/diagnóstico , Infección Latente/tratamiento farmacológico , Masculino , Microscopía , Persona de Mediana Edad , Nitroimidazoles/uso terapéutico , Carga de Parásitos , Parasitemia/complicaciones , Parasitemia/diagnóstico , Parasitemia/tratamiento farmacológico , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Tripanocidas/uso terapéutico , Trypanosoma cruzi , Carga Viral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...